Indication : In Major Depressive disorder.
Major Depressive Disorder is a serious mental health condition characterized by persistent sadness, loss of interest in activities, and impaired daily functioning. It differs from normal sadness by its severity, duration (symptoms last ≥2 weeks), and significant impact on life
MOA : The clinical effect of desvenlafaxine occurs via potentiation of serotonin and norepinephrine in CNS.
